Zadnji put ažurirano :
28/04/2024
Opća anestezija   Thiopental sodium  
Injekcija
Stabilizacija rješenja Stabilnost mješavine Stabilizacijski faktor Kompatibilnosti Način davanja lijeka Bibliografija Pdf
   Kemijska struktura  

Nekomercijalni   Nekomercijalni     

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Anapental Egipat
Anental Kolumbija, Venecuela
Epental Saudijska Arabija
Exipental Iran
Farmotal Italija
Gabapentax Kolumbija
Hipnopento Argentina
Nesdonal Nizozemska
Pantul Ekvador, Peru
Pensodital Meksiko
Pental Turska
Pentarim Meksiko
Pentax Venecuela
Pentocur Island, Norveška
Pentotex Malezija
Pentothal Australija, Belgija, Danska, Finska, Grčka, Italija, Kanada, Luksemburg, Meksiko, Švedska, Švicarska
Sodipental Kolumbija, Meksiko
Thiojex Čile
Thiomek Peru
Thiopental Austrija, Egipat, Francuska, Grčka, Iran, Irska, Madžarska, Malezija, Maroko, Njemačka, Poljska, Rumunjska, Saudijska Arabija, Tunis, Velika Britanija
Thiopentax Ekvador, Venecuela
Tiobarbital Kolumbija, Španjolska
Trapanal Njemačka
Zedisol Meksiko
Bibliografija   Injekcija   Bibliografija : Thiopental sodium  
Vrsta Publikacija
59 Časopis Trissel LA, Gilbert DL, Martinez JF, Kim MC.
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
125 Časopis Chernin EL, Stewart JT, Smiler B.
Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4°C.
Am J Health-Syst Pharm 1996 ; 53: 1576-1579.
126 Časopis Prankerd RJ, Jones RD.
Physicochemical compatibility of propofol with thiopental sodium.
Am J Health-Syst Pharm 1996 ; 53: 2606-2610.
299 Časopis Trissel LA, Martinez JF, Gilbert DL.
Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
314 Časopis Chiu MF, Schwartz ML.
Visual compatibility of injectable drugs used in the intensive care unit.
Am J Health-Syst Pharm 1997 ; 54: 64-65.
319 Časopis Hadzija BW, Lubarsky DA.
Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia.
Am J Health-Syst Pharm 1995 ; 52: 997-999.
350 Časopis Martens HJ, De Goede PN, Van Loenen AC.
Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers.
Am J Hosp Pharm 1990 ; 47: 369-373.
527 Časopis Das Gupta V, Neal Gardner S, Jolowsky CM, Newcomer DR, Stewart KR.
Chemical stability of thiopental sodium injection in disposable plastic syringes.
J Clin Pharm Ther 1987 ; 12: 339-342.
642 Časopis Baumgartner TG, Knudsen AK, Dunn AJ, Kilroy RA.
Norepinephrine stability in saline solutions.
Hosp Pharm 1988 ; 23: 44,49, 59.
755 Laboratorija Pancuronium (Pavulon®) - Résumé des caractéristiques du produit
MSD France 2016
871 Časopis Haws JL, Herman N, Clark Y, Bjoraker R, Jones D.
The chemical stability and sterility of sodium thiopental after preparation.
Anesth Analg 1998 ; 86: 208-213.
919 Časopis Lazar ER, Jolly DT, Tam YK, Hrazdil J, Tawfik SR, Clanachan AS.
Propofol and thiopental in a 1:1 volume mixture is chemically stable.
Anesth Analg 1998 ; 86: 422-426.
1173 Časopis Kowaluk EA, Roberts MS, Blackburn HD, Polack AE.
Interactions between drugs and polyvinyl chloride infusion bags.
Am J Hosp Pharm 1981 ; 38: 1308-1314.
1713 Časopis Trissel LA, Saenz CA.
Compatibility screening of bivalirudin during simulated Y-site administration with other drugs.
Int J Pharm Compound 2002 ; 6: 311-315.
1721 Časopis Trissel LA, Williams KY, Baker MB.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Int J Pharm Compound 2001 ; 5: 69-72.
1803 Časopis Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB.
Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2003 ; 60: 80-85.
2073 Časopis Taniguchi T, Yamamoto K, Kobayashi T.
Precipitate formed by thiopentone and vecuronium causes pulmonary embolism.
Can J Anesth 1998 ; 45: 347-351.
2079 Časopis Morton WD, Lerman J.
The effect of pancuronium on the solubility of aqueous thiopentone.
Can J Anesth 1987 ; 34: 87-89.
2090 Časopis Pere H, Chasse V, Forest JM, Hildgen P.
Compatibility of injectable pantoprazole in Y-site administration.
Pharmactuel 2004 ; 37: 193-196.
2105 Časopis Valverde molina F, Hernandez Hernandez G, Munoz Castillo M, Novales Duran J, Gallego Fernandez C.
Estabilidad de una mezcla de etomidato y pentotal para administracion intravenosa en bolo.
Farm Hosp 1999 ; 23: 357-360.
2146 Časopis Trissel LA, Xu QA, Baker M.
Drug compatibility with new polyolefin infusion solution containers.
Am J Health-Syst Pharm 2006 ; 63: 2379-2382.
2231 Časopis de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3134 Časopis Perez Jua En, Maqueda Palau M, Arévalo Rubert Mt, Ribas Nicolau B, Amoros Cerdà SM.
Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua.
Enferm Intensiva 2010 ; 21: 96-103.
3212 Časopis Ribas Nicolau, B.; P?rez Juan, E.; Amor?s Cerd?, S.M.; Ar?valo Rubert, M.J.; Maqueda Palau, M.
Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos.
Enferm Intensiva 2011 ;22:78-82.
3372 Časopis Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S.
Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine.
Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3373 Časopis Khan S, Stannard N, Greijn J.
Precipitation of thiopental with muscle relaxants: a potential hazard.
J R Soc Med Sh Rep 2011 ; 2: 58.
3377 Časopis Huddy NC, Durcan JJ.
Precipitation betwen meptazinol and thiopentone.
Anaesthesia 1983 ; 38: 601-602.
3408 Časopis Tollec S, Touzin K, Pelletier E, Forest J.M.
Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels.
Pharmactuel 2013 ; 46, 1 : 16-21.
3464 Časopis Monica Maqueda-Palau, Eva Pérez-Juan, Maria Josep Arévalo-Rubert, Sylvia Monica Amoros-Cerda, Bàrbara Ribas-Nicolau.
Compatibilidad física de la amiodarona en perfusión continua
Enferm Clin 2011 21:25-29.
3466 Časopis B. Ribas Nicolau, E. P?rez Juan, S.M. Amor?s Cerd?, M.J. Ar?valo Rubert, M. Maqueda Palau.
Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos
Enferm Intensiva 2011 ;22:78-82.
3501 Laboratorija Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics
Pfizer 2011
3503 Laboratorija Fentanyl - Summary of product Characteristics
Hameln Pharmaceuticals 2012
3525 Laboratorija Pethidine hydrochloride - Summary of product Characteristics
AMCO Amdipharm Mercury 2012
3526 Laboratorija Clindamycin (Dalacin®) - Summary of Product Characteristics
Pharmacia 2010
3531 Laboratorija Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics
Wockhardt 2014
3549 Laboratorija Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3564 Laboratorija Rocuronium B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3599 Laboratorija Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics
Amco Amdipharm Mercry 2013
3600 Laboratorija Hydroxyzine (Atarax®) - Résumé des caractéristiques du produit
UCB Pharma SA 2009
3601 Laboratorija Cisatracurium Actavis - Résumé des Caractéristiques du Produit
Actavis 2012
3607 Laboratorija Esmolol hydrochloride for injection - Summary of Product Characteristics
AOP Orphan Pharmaceuticals AG 2013
3612 Laboratorija Doxapram (Dopram) - Summary of Product Characteristics
Amdipharm Mercury Company 2012
3614 Laboratorija Nicardipine Injection - Summary of Product Characteristics
American Regent Inc 2013
3629 Laboratorija Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics
Actavis UK 2014
3630 Laboratorija Vecuronium (Norcuron®) - Summary of Product Characteristics
Merck Sharp Dohme 2012
3631 Laboratorija Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit
Aguettant 2016
3674 Laboratorija Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3675 Laboratorija Thiopental sodium - Summary of Product Characteristics
Archimedes Pharma UK Ltd 2015
3676 Laboratorija Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit
Hospira 2014
3767 Časopis Legris M.E, Lavoie A, Forrest J.M, Hildgen P.
Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels.
Pharmactuel 2014 ; 47, 3 : 167-172.
3823 Časopis Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R.
Compatibilité physique de médicaments administrés dans l’unité de soins intensifs
Pharmactuel 2015 ; 48, 3 : 146-152.
3932 Laboratorija Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
Serb Laboratoire 2015
3941 Laboratorija Nicardipine - Summary of Product Characteristics
Concordia International 2017
4009 Laboratorija
Droperidol - Résumé des Caractéristiques du Produit
Panpharma 2017
4428 Časopis Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J.
Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma.
J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132.
4700 Laboratorija Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics
AS Kalceks 2022

  Mentions Légales